Literature DB >> 33552359

A 0.85% saline as alternative detection buffer for SD-Bioline HIV rapid test in resource limited setting.

Shabani Iddi1, Evangelista Malindisa1, Musa Shija2, Betrand Msemwa2, Vitus Silago2, Mariam Mirambo2, Stephen Mshana2.   

Abstract

Accuracy in the diagnosis is a key step to identify HIV infected individuals for appropriate management. Insufficient supply of manufacturer´s buffers in relation to the number of strips per kit has negative impact on patient´s results hence improper patient´s management. In resource limited settings, some laboratory staff use different substitute buffers which has never been validated on their reliability. This study aimed at comparing the performance of 0.85% saline and SD-Bioline manufacturer´s buffer in detection of HIV antibodies. A total of 220 whole blood specimens: 110 HIV positive specimens from patients attending care and treatment center (CTC) and 110 HIV negative specimens from blood donors were re-tested for HIV status using SD-Bioline HIV rapid test using manufacturer´s buffer and 0.85% saline separately. Data and laboratory results were recorded in Microsoft excel sheet followed by analysis using STATA version 13. For all tested samples, the level of agreement between 0.85% saline and manufacturer´s buffer was 98.64% (kappa=0.9727). The value of kappa indicates very good agreement between 0.85% saline and manufacturer´s buffer. In incidents where manufacturer´s buffer is not sufficient, 0.85% saline can give reliable results. Further studies to evaluate the suitable buffer for other rapid tests for HIV and other diseases are recommended especially in resource limited settings. Copyright: Shabani Iddi et al.

Entities:  

Keywords:  0.85% saline; HIV infections; buffer; serologic tests

Year:  2020        PMID: 33552359      PMCID: PMC7847209          DOI: 10.11604/pamj.2020.37.241.24234

Source DB:  PubMed          Journal:  Pan Afr Med J


  3 in total

Review 1.  Global burden of disease in young people aged 10-24 years: a systematic analysis.

Authors:  Fiona M Gore; Paul J N Bloem; George C Patton; Jane Ferguson; Véronique Joseph; Carolyn Coffey; Susan M Sawyer; Colin D Mathers
Journal:  Lancet       Date:  2011-06-07       Impact factor: 79.321

2.  Scaling up HIV rapid testing in developing countries: comprehensive approach for implementing quality assurance.

Authors:  Bharat S Parekh; Mireille B Kalou; George Alemnji; Chin-Yih Ou; Guy-Michel Gershy-Damet; John N Nkengasong
Journal:  Am J Clin Pathol       Date:  2010-10       Impact factor: 2.493

3.  Buffer substitution in malaria rapid diagnostic tests causes false-positive results.

Authors:  Philippe Gillet; Marcella Mori; Jef Van den Ende; Jan Jacobs
Journal:  Malar J       Date:  2010-07-22       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.